Quotient Sciences Limited

Roche’s Genentech terminates licencing deal with Norwegian biotech

Genentech is ending a license collaboration with Norwegian biotech Nykode Therapeutics regarding a clinical stage cancer vaccine program.

Clinigen Clinical Supplies Management GmbH

CTC Clinical Trial Consultants AB

Scientific Solutions

ZEISS Hosts an exceptional Global Conference on Innovation and Production in Berlin

More than 50 distinguished speakers from leading manufacturing companies.

Lilly´s Nordic manager on Mounjaro launch in Sweden: "Patients deserve respect"

Another blockbuster diabetes and obesity drug has made its way into the Swedish market – with promises of a stable supply and availability for patients. “What w...

Kompauto Nordic AB

Immedica högt på listan över Sveriges bästa arbetsplatser

Stockholmsbaserade Immedica Pharma hamnar tvåa på listan över Sveriges bästa arbetsplatser i kategorin medelstora organisationer. Även andra läkemedelsföretag f...

From the sea of Åland to a self-test for lithium

Four years ago, a meeting on the sea of Åland resulted in the development of a self-test for lithium levels in the blood. The hopes are that the test will be av...

Study names with an attitude – more important than you might think

Ironman, T-rex, Star-Trek. Popcorn, Proper, Scout. Nope, these are neither fantasy films nor dog names. They’re the names of ongoing cancer studies in Sweden.

Are you curious about volume imaging for very large samples?

Exciting ZEISS Webinar!

Metabolon

AI automates testing of implant coatings

The medical technology group Smith+Nephew uses an AI-supported light microscope ZEISS Axio Imager to inspect coated implants.

High-performance Slide Scanner for Fluorescence, Brightfield and Polarization

ZEISS Axioscan 7.

Unmatched performance and flexibility in its class

The new ZEISS SPECTRUM family is equipped to be the ideal match from measuring small electronics up to larger housings.

Norwegian cancer research companies merge

The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.

Extremely high sample throughput rates

Precision and reliability in automated liquid handling

JMP Statistical Discovery

Optimize Courier SUPPLIERS (DISTRIBUTORS)

Pharma Relations AB

On the hunt for high throughput diagnostics

Global diagnostics companies and laboratories are in a race against time to adapt testing capacity to current demand. Due to the global COVID 19 pandemic, the d...

Svensk vaccinutvecklare får 24 miljoner av brittiskt forskningsprogram

Abera Bioscience får upp till motsvarande cirka 24 miljoner kronor i finansiering från ett brittiskt program inriktat på vacciner som ska stoppa epidemier i låg...

Aberas teknik får patentgodkännande av EU

Vaccin- och bioteknikbolaget Abera Bioscience, som utvecklar vacciner som nässpray, har fått ett patentgodkännande av den europeiska patentmyndigheten, EPO.